Latest News and Press Releases
All News
10
Everything
Wolf Haldenstein Adler Freeman & Herz LLP is investigating DoubleVerify Holdings Inc. for potential violations of securities laws
March 13, 2025 10:30 ET
|
Wolf Haldenstein Adler Freeman & Herz LLP
PLEASE CLICK HERE TO PROVIDE YOUR CONTACT INFORMATION NEW YORK, March 13, 2025 (GLOBE NEWSWIRE) -- Wolf Haldenstein Adler Freeman & Herz LLP ("Wolf Haldenstein"), a preeminent national...
Global Compact Construction Equipment Market to Witness Substantial Growth USD 48.2 billion by 2035 | FMI Reports
March 13, 2025 10:30 ET
|
Future Market Insights Global and Consulting Pvt. Ltd.
NEWARK, Del:, March 13, 2025 (GLOBE NEWSWIRE) -- The compact construction equipment market is anticipated to expand from USD 35.6 billion in 2025 to USD 48.2 billion by 2035, reflecting a CAGR of...
GreenCars Sponsors the #EVRealityCheck Zone at Electrify Expo 2025 to Debunk EV Myths
March 13, 2025 10:30 ET
|
Electrify Expo
MEDFORD, Ore. and AUSTIN, Texas, March 13, 2025 (GLOBE NEWSWIRE) -- GreenCars, a leading resource for electric vehicle (EV) education and adoption, is proud to announce its sponsorship of the...
Foundation for Opioid Response Efforts Awards Grant to Tradeoffs to Expand Reporting on Opioid and Overdose Crisis
March 13, 2025 10:30 ET
|
Foundation for Opioid Response Efforts
New York, March 13, 2025 (GLOBE NEWSWIRE) -- The Foundation for Opioid Response Efforts (FORE) has awarded a $65,702 grant to Tradeoffs, a nonprofit health care news organization, to support new...
Peoples Bancorp Announces Authorization of Stock Repurchase Plan
March 13, 2025 10:29 ET
|
Peoples Bancorp of North Carolina, Inc.
NEWTON, N.C., March 13, 2025 (GLOBE NEWSWIRE) -- Peoples Bancorp of North Carolina, Inc. (Nasdaq: PEBK), the parent company of Peoples Bank, Newton, NC announced today that its Board of Directors...
Point of Care Data Management Software Markets, 2025-2030 - The Shift to Value-Based Care Fuels Demand for Advanced Data Management Software at the Point of Care
March 13, 2025 10:27 ET
|
Research and Markets
Dublin, March 13, 2025 (GLOBE NEWSWIRE) -- The "Point of Care Data Management Software - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.The global...
NNIT A/S: Resolutions from the annual general meeting of NNIT A/S
March 13, 2025 10:24 ET
|
NNIT A/S
Today, NNIT A/S held its annual general meeting, at which the following were noted/approved: Financial year 2024 and 2025 The Chairman of the Board gave the Board of Directors’ report on the...
Kidney Cancer Drugs Industry Report 2025: Growth Analysis for Targeted Therapy, Immunotherapy, Angiogenesis Inhibitors, mTOR Inhibitors, Monoclonal Antibodies, and Cytokine Immunotherapy (IL-2)
March 13, 2025 10:24 ET
|
Research and Markets
Dublin, March 13, 2025 (GLOBE NEWSWIRE) -- The "Kidney Cancer Drugs - Global Strategic Business Report" has been added to ResearchAndMarkets.com's offering.The global market for Kidney Cancer Drugs...
U.S. Convenience Retailers Market Report 2025: Consolidation Continues Across the Industry
March 13, 2025 10:21 ET
|
Research and Markets
Dublin, March 13, 2025 (GLOBE NEWSWIRE) -- The "Convenience Retailers in the US" report has been added to ResearchAndMarkets.com's offering.The value sales of convenience retailers are split...
Academy of Nutrition and Dietetics Celebrates Nutrition and Dietetics Technician, Registered Day, March 13, During National Nutrition Month®
March 13, 2025 10:20 ET
|
Academy of Nutrition and Dietetics
Chicago, March 13, 2025 (GLOBE NEWSWIRE) -- Today, March 13, the Academy of Nutrition and Dietetics is proud to shine a spotlight on the important work of nutrition and dietetics technician,...
- March 13, 2025 10:27 ET Point of Care Data Management Software Markets, 2025-2030 - The Shift to Value-Based Care Fuels Demand for Advanced Data Management Software at the Point of Care
- March 13, 2025 10:24 ET Kidney Cancer Drugs Industry Report 2025: Growth Analysis for Targeted Therapy, Immunotherapy, Angiogenesis Inhibitors, mTOR Inhibitors, Monoclonal Antibodies, and Cytokine Immunotherapy (IL-2)